EGX - Delayed Quote • USD Delta Co. For Printing & Packaging S.A.E (EGS370W1C013.CA) Follow Add holdings 76.92 +1.00 +(1.32%) As of 12:21:59 PM GMT+3. Market Open. Related News Stock market today: Dow, S&P 500, Nasdaq futures fall as US-China trade tensions flare up again US stock futures edged lower Sunday evening, following a bullish May driven by tech optimism and resilient economic data. Moderna gains as FDA nod for next-gen COVID-19 vaccine Investing.com -- Moderna (NASDAQ:MRNA) saw its shares rose nearly 5% in premarket trading Monday after the U.S. Food and Drug Administration (FDA) has approved the drugmaker’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults 65 and older, as well as individuals aged 12 to 64 with at least one underlying condition that increases their risk of severe illness. Exclusive-Tesla executives questioned Musk after he denied killing $25,000 EV project - sources (Reuters) -Some senior Tesla executives were alarmed last year when Elon Musk denied a Reuters report that the company had killed a planned all-new $25,000 EV that investors had expected to drive explosive vehicle sales growth, according to people familiar with the matter. “Reuters is lying,” Musk had posted on X, minutes after the story published on April 5, 2024, halting a 6% decline in Tesla’s stock. Tesla shares recovered some of the loss after Musk's post, but the stock was down 3.6% at market close. Trump Warns of 50% Tariffs on Imported Steel, Aluminum; Partners Threaten Countermeasures US President Donald Trump threatened Friday to raise steel tariffs to 50% from a previous import dut Tesla sales in Norway soar 213% in May, driven by Model Y demand Investing.com -- Tesla (NASDAQ:TSLA)’s new car sales in Norway surged by 213% in May compared to the same month last year, reaching 2,600 vehicles, as per registration data released on Monday. These Stocks Are Moving the Most Today: Cleveland-Cliffs, Steel Dynamics, Tesla, NIO, Blueprint Medicines, Moderna, and More Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%. Dollar Exposed to Persistent Weakness in Next 12 Months, Says Morgan Stanley The dollar fell to a six-week low against a basket of currencies and Morgan Stanley expects it to continue to weaken over the next 12 months. Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy? Ivonescimab failed to produced a statistically significant overall survival benefit in the phase 3 Harmoni trial. Shares of Summit Therapeutics (NASDAQ: SMMT) tanked more than 30% on Friday, May 30. Stock markets have a tendency to sell first and ask questions later. Oil Advances as OPEC+ Supply Boost Vies With Geopolitical Risk (Bloomberg) -- Oil advanced after OPEC+ increased production less than some had feared and geopolitical concerns flared over Ukraine and Iran.Most Read from BloombergBillionaire Steve Cohen Wants NY to Expand Taxpayer-Backed FerryWhere the Wild Children’s Museums AreNow With Colorful Blocks, Tirana’s Pyramid Represents a Changing AlbaniaThe Economic Benefits of Paying Workers to MoveNYC Congestion Toll Brings In $216 Million in First Four MonthsThe Organization of the Petroleum Exporting Countri Sanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to Pipeline The pharma giant wants to refreshen its portfolio after some of its internal development programs disappointed in clinical trials. Oil prices surge on relief over OPEC+ output hike Oil prices surged on Monday morning, after OPEC+ announced an increase to output for July that was in line with expectations. Tesla Stock Is Falling. Is It a ‘Sell the News’ Month? Tesla is set to launch its highly anticipated robotaxi service this month. Will that drive shares higher or will investors take profits now that the seminal event has arrived? Palantir vs. Alphabet Stock: Wall Street Says Buy One and Sell the Other Both of these AI-fueled tech sector leaders are producing great financial results, but the market has drastically different price outlooks for them. Steel Stocks Soar After Trump’s Bombshell Tariff Announcement President Trump said tariffs on imported steel would go to 50% from 25%. That has investors excited early Monday. Tesla sales in Norway rise 213% year-on-year in May OSLO (Reuters) -Tesla's sale of new cars in Norway rose by 213% in May from a year ago to 2,600 vehicles, registration data showed on Monday, boosted by a revamped Model Y compact SUV, the country's best-selling automobile in each of the last three years. Year-to-date sales rose by 8.3% from the first five months of 2024. Nine out of ten new cars sold in Norway last year were fully electric vehicles, and the EV share of sales year-to-date stands at 92.7%, the Norwegian Road Federation said, bringing it close to a goal of phasing out diesel and petrol automobiles. BYD Shares Sink as Carmaker Faces Backlash Over EV Price War (Bloomberg) -- BYD Co. shares fell, bringing losses over the past week to more than 17%, on concern that its price cuts are drawing government scrutiny and becoming unsustainable for the Chinese EV industry.Most Read from BloombergBillionaire Steve Cohen Wants NY to Expand Taxpayer-Backed FerryWhere the Wild Children’s Museums AreNow With Colorful Blocks, Tirana’s Pyramid Represents a Changing AlbaniaThe Economic Benefits of Paying Workers to MoveNYC Congestion Toll Brings In $216 Million in Fir FTSE 100 LIVE: Markets slide as China accuses US of violating trade deal Markets were volatile on Monday as Trump's tariff war continues to play out. Tesla not keen on local production, minister says, as India finalises EV policy NEW DELHI (Reuters) -Tesla does not want to produce cars in India, a federal minister said on Monday as the government finalised its electric vehicle policy, with the EV giant's plans currently focused on importing cars into the country. India will significantly cut import taxes for foreign automakers that pledge to invest in domestic EV production lines. The policy, which has been in the works for a year, was originally designed to attract Tesla to set up manufacturing in the country but CEO Elon Musk put his investment plans for India on hold last year. Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other KIT-driven diseases, have entered into an agreement under which Sanofi will acquire Blueprint. Sanofi to buy US biopharma group Blueprint for up to $9.5 billion PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a European healthcare company so far this year, according to LSEG data. Blueprint is a specialist in treatments for systemic mastocytosis, a rare blood disorder. The two companies said on Monday that Sanofi would initially pay $129.00 per share in cash, or around $9.1 billion.